WEE1 and cancer: Selonsertib is a serine/threonine-protein kinase inhibitor that reverses the multidrug resistance properties of cancer cells by inhibiting the overexpression of ATP-binding cassette (ABC) transporters and reducing the proliferation of cancer cells (30).